Kyprolis 60 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9W92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,051
Award facts
- Contract value 100% obligated
- $35,050.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,050.56 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for the supply of Kyprolis 60 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of February 4, 2026, and represents a non-set-aside competitive award. The contract will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. Kyprolis (carfilzomib) is a proteasome inhibitor used in oncology treatment, reflecting the critical pharmaceutical commodities supplied through DLA's medical supply chain to support military healthcare operations.
This delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering specialty medications, brand-name and generic drugs, vaccines, and other critical medical supplies to military treatment facilities and veterans' healthcare programs globally. Amerisourcebergen's selection as a prime vendor demonstrates its established capability to meet federal pharmaceutical procurement requirements through competitive procurement and its role as a critical distributor within the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9W92?
SPE2DR26F9W92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9W92 worth?
The government has obligated $35,051 on SPE2DR26F9W92.
Is contract SPE2DR26F9W92 an order under another contract?
Yes. SPE2DR26F9W92 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9W92 competed?
The extent of competition for SPE2DR26F9W92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award